Skip to content

HQL

Tekla Life Sciences Investors

NYSE · Financial Services · Asset Management · US

$20.64
−0.34%
Ask drillr
Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
P/E (Fwd)
EV/EBITDA
3.2x
Market Cap
$595.93M
RSI (14)
44.8
1D Return
−0.34%
YTD Return
+22.23%
SummaryUpdated Mar 1, 2026

Tekla Life Sciences Investors (NYSE:HQL) is a closed-end investment fund that has been operating since 1992, making it one of the longest-running specialized life sciences investment vehicles in the public markets. Originally known as H&Q Life Sciences Investors, the fund was launched during the early boom years of biotechnology investing and has since evolved to become a focused player in the life sciences investment space. The fund is managed by Tekla Capital Management LLC and trades as a publicly listed closed-end fund, allowing individual and institutional investors to gain exposure to a diversified portfolio of life sciences companies through a single investment vehicle.

Similar companies

Latest newsMore news →

No recent news for HQL.